Pharmaceutical Shortages and Heart Health Innovations

This chapter explores the pharmaceutical industry's challenges in addressing drug shortages, particularly for obesity and heart failure treatments. It highlights recent advancements in GLP-1 medications, showcasing a trial that demonstrates weight loss and improved heart failure symptoms. The discussion also emphasizes the implications of these treatments on patient quality of life and the ongoing debate about their long-term safety and accessibility.